Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
publication
Title:
The Direct Peptide Reactivity Assay: Selectivity of Chemical Respiratory Allergens
Author:
Lalko JF, Kimber I, Gerberick GF, Foertsch LM, Api AM & Dearman RJ
Year:
2012
Bibliographic source:
Toxicological Sciences 129(2): 421–431

Materials and methods

Type of sensitisation studied:
respiratory
Study type:
other: direct peptide reactivity assay (DPRA)

Results and discussion

Applicant's summary and conclusion

Conclusions:
Chlorhexidine was tested in the direct peptide reactivity assay (DPRA) and failed to react with either peptide. Therefore, chlorhexidine was judged as a nonsensitizing substance.
Executive summary:

Chlorhexidine was tested in the direct peptide reactivity assay (DPRA), i.e. known skin and respiratory sensitizers were reacted with synthetic peptides containing either lysine (Lys) or cysteine (Cys) for 24 h. The samples were analysed by HPLC/UV, and the loss of peptide from the reaction mixture was expressed as the percent depletion compared with the control. The potential for preferential reactivity was evaluated by comparing the ratio of Lys to Cys depletion (Lys:Cys ratio). Chlorhexidine failed to react with either peptide. Based on previous experience, depletion of less than 10% is typically associated with nonsensitizing chemicals or, in some cases, pre-/prohaptens.